References
- AdembriC, NovelliA.Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance.Clin Pharmacokinet.2009;48(8):517–28.
- PetrosilloN, GiannellaM, LewisR, VialeP.Treatment of carbapenem-resistant klebsiella pneumoniae: the state of the art.Expert Rev Anti-infect Ther.2013;11(2):159–77.
- RobertsJA, LipmanJ.Pharmacokinetic issues for antibiotics in the critically ill patient.Crit Care Med.2009;37(3):840–51.
- ChoiG, GomersallCD, TianQ, JoyntGM, FreebairnR, LipmanJ.Principles of antibacterial dosing in continuous renal replacement therapy.Crit Care Med.2009;37(3):2268–82.
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for industry: bioanalytical method validation. Silver Spring, MD: FDA; 2001.
- International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q2 (R1): Validation of analytical procedures: text and methodology. Geneva: ICH; 2005.
- AnnesleyTM.Ion suppression in mass spectrometry.Clin Chem.2003;49(7):1041–4.
- MoutonJW, BrownDF, ApfalterP, CantónR, GiskeCG, IvanovaM, et al.The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.Clin Microbiol Infect.2012;18(3):E37–45.
- ReynsT, de BaereS, CroubelsS, de BackerP.Determination of clavulanic acid in calf plasma by liquid chromatography tandem mass spectrometry.J Mass Spectrom.2006;41(11):1414–20.
- ReynsT, de BoeverS, de BaereS, de BackerP, CroubelsS.Quantitative analysis of clavulanic acid in porcine tissues by liquid chromatography combined with electrospray ionization tandem mass spectrometry.Anal Chim Acta.2007;597(2):282–9.
- FagerquistCK, LightfieldAR, LehotaySJ.Confirmatory and quantitative analysis of beta-lactam antibiotics in bovine kidney tissue by dispersive solid-phase extraction and liquid chromatography-tandem mass spectrometry.Anal Chem.2005;77(5):1473–82.
- MastovskaK, LightfieldAR.Streamlining methodology for the multiresidue analysis of beta-lactam antibiotics in bovine kidney using liquid chromatography-tandem mass spectrometry.J Cromatogr A.2008;1202(2):118–23.
- ArzuagaA, IslaA, GasconAR, MaynarJ, MartinA, SolinisMA, et al.Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.Biomed Chromatogr.2005;19(8):570–8.
- OhmoriT, SuzukiA, NiwaT, UshikoshiH, ShiraiK, YoshidaS, et al.Simultaneous determination of eight beta-lactam antibiotics in human serum by liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci.2011;879(15–16):1038–42
- PhillipsOA, Abdel-HamidME, Al-HassawiNA.Determination of linezolid in human plasma by LC–MS–MS.Analyst.2001;126(5):609–14.
- European Committee on Antimicrobial Scusceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2014. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_3.1.pdf (accessed 30 March 2014).
- ZavaskiAP, BulittaJB and LandersdorferCB.Combination therapy for carbapenem-resistant Gram-negative bacteria.Expert Rev Anti-infect Ther.2013;11(12):1333–53.
- Clinical Investigation of Medicinal Products in the Paediatric Population E11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step 4 version. Geneva: ICH; 2000. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E11/Step4/E11_Guideline.pdf (accessed 30 March 2014).